tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BMY Stock Latest News

Bristol Myers price target raised to $52 from $51 at Wells Fargo
The FlyBristol Myers price target raised to $52 from $51 at Wells Fargo
2d ago
BMY
Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 months
PremiumThe Fly
Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 months
12d ago
BMY
Bristol Myers presents new data from Phase 3 EMERGENT program evaluating KarXT
PremiumThe Fly
Bristol Myers presents new data from Phase 3 EMERGENT program evaluating KarXT
13d ago
BMY
Bristol Myers presents new interim long-term efficacy data from EMERGENT-4 trial
PremiumThe Fly
Bristol Myers presents new interim long-term efficacy data from EMERGENT-4 trial
13d ago
BMY
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
PremiumThe Fly
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
15d ago
BMY
TSVT
Standard BioTools announces multi-year agreement with Bristol Myers
PremiumThe FlyStandard BioTools announces multi-year agreement with Bristol Myers
17d ago
BMY
LAB
Bristol Myers: European Commission expands approval of Reblozyl
PremiumThe Fly
Bristol Myers: European Commission expands approval of Reblozyl
17d ago
BMY
Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints
PremiumThe Fly
Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints
19d ago
BMY
ZLAB
Ex-Dividend Date Nearing for These 10 Stocks – Week of April 1, 2024
PremiumMarket News
Ex-Dividend Date Nearing for These 10 Stocks – Week of April 1, 2024
20d ago
GL
BMY
Bristol Myers ends collaboration agreement with Molecular Templates
PremiumThe Fly
Bristol Myers ends collaboration agreement with Molecular Templates
22d ago
BMY
MTEM
Bristol Myers Squibb (NYSE:BMY) Slips after Disappointing Drug Trial
PremiumMarket News
Bristol Myers Squibb (NYSE:BMY) Slips after Disappointing Drug Trial
22d ago
BMY
Bristol Myers says KRYSTAL-12 trial met primary endpoint in PFS
PremiumThe Fly
Bristol Myers says KRYSTAL-12 trial met primary endpoint in PFS
23d ago
BMY
Bristol Myers: Phase 3 YELLOWSTONE trial did not meet primary endpoint
PremiumThe FlyBristol Myers: Phase 3 YELLOWSTONE trial did not meet primary endpoint
23d ago
BMY
Bristol Myers Squibb call volume above normal and directionally bullish
PremiumThe Fly
Bristol Myers Squibb call volume above normal and directionally bullish
26d ago
BMY
Bristol Myers’ Abecma approved in the EU for multiple myeloma
PremiumThe Fly
Bristol Myers’ Abecma approved in the EU for multiple myeloma
1M ago
BMY
Bristol Myers says Phase 3 CheckMate -9DW trial met primary endpoint
PremiumThe Fly
Bristol Myers says Phase 3 CheckMate -9DW trial met primary endpoint
1M ago
BMY
Bristol Myers announces the Phase 3 CheckMate -9DW trial
PremiumThe Fly
Bristol Myers announces the Phase 3 CheckMate -9DW trial
1M ago
BMY
This radiopharma name seen as ‘poised for takeout’ following Fusion deal
PremiumThe Fly
This radiopharma name seen as ‘poised for takeout’ following Fusion deal
1M ago
AZN
BMY
Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim
PremiumThe Fly
Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim
1M ago
AZN
BMY
Gerald Storch Exits, Bristol-Myers Squibb Board Shrinks
PremiumCompany AnnouncementsGerald Storch Exits, Bristol-Myers Squibb Board Shrinks
1M ago
8K
BMY
Arcellx price target raised to $81 from $72 at Needham
PremiumThe Fly
Arcellx price target raised to $81 from $72 at Needham
1M ago
BMY
JNJ
Bristol Myers completes acquisition of Karuna Therapeutics
PremiumThe Fly
Bristol Myers completes acquisition of Karuna Therapeutics
1M ago
BMY
KRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >